Skip to main content
Premium Trial:

Request an Annual Quote

Structural Bioinformatics Partners with Japanese Pharmaceutical Firm

Premium

SAN DIEGO, Calif.--Structural Bioinformatics, maker of supercomputational operating systems here, announced that it initiated a drug discovery partnership with Japan's third largest pharmaceutical firm, Yamanouchi Pharmaceu tical of Tokyo.

Structural Bioinfor matics will develop a list of required characteristics for an undisclosed small molecule drug candidate using its own algorithms and computational skills, based on the dynamic shape of Yamanou chi's protein molecule target. These characteristics will then be screened by computer against a database of molecules, to discover candidates for development into drugs. The process is a speedier and less costly process than high-throughput screening, according to the bioinformatics firm.

NCGR Will Publish Electronic Journal of Agricultural Genomics SANTA FE, N.M.--The National Center for Genome Resources here announced that as part of its burgeoning public program in agricultural genomics, it has partnered with the electronic genetic research publication Journal of Quantitative Trait Loci to develop, expand and rename the journal. The Journal of Agricultural Genomics will be hosted on the center's agricultural genomics web site at http://www.ncgr.org/ag.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.